This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: University of Montana, University of Washington. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 69 
1 out of 2,169 
Years Active: 2018
Title: Nicolas Guilloteau: Innovator in Cytochrome P450 Research
Introduction
Nicolas Guilloteau is a notable inventor based in Missoula, MT (US). He has made significant contributions to the field of biochemistry, particularly in the area of cytochrome P450 research. His work focuses on developing specific inhibitors that can have therapeutic applications.
Latest Patents
Guilloteau holds a patent for "Specific inhibitors of cytochrome P450 26 retinoic acid hydroxylase." This patent is directed towards compositions and methods for treating diseases that can be improved by inhibiting CYP26 mediated retinoic acid metabolism. The compositions include compounds that are designed to interact with various chemical groups, showcasing his innovative approach to drug development.
Career Highlights
Throughout his career, Guilloteau has worked with prestigious institutions such as the University of Washington and the University of Montana. His research has contributed to a deeper understanding of metabolic processes and potential therapeutic interventions.
Collaborations
Guilloteau has collaborated with notable colleagues in his field, including Philippe Diaz and Nina Isoherranen. These partnerships have enhanced his research and expanded the impact of his work.
Conclusion
Nicolas Guilloteau's contributions to the field of biochemistry through his innovative patent and collaborations highlight his role as a significant inventor. His work continues to influence the development of treatments for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile